Surveillance and Epidemiologic Research of Duchenne and Becker Muscular Dystrophy
The summary for the Surveillance and Epidemiologic Research of Duchenne and Becker Muscular Dystrophy grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
Surveillance and Epidemiologic Research of Duchenne and Becker Muscular Dystrophy: . The purpose of this program is to establish a five year cooperative agreement to provide people with Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) and their families with better clinical, outreach and counseling services through strengthening public health agencies and health care providers. The purpose is also to support the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) surveillance system to: (a) characterize the epidemiology of DMB and BMD and their complications; and (b) develop long-term follow-up and tracking of children with DMD and BMD identified technologies to describe the history and outcome of treated cases and/or those cases with treatments not consistent with protocol standards.
|Federal Grant Title:||Surveillance and Epidemiologic Research of Duchenne and Becker Muscular Dystrophy|
|Federal Agency Name:||Centers for Disease Control and Prevention|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||CDC-RFA-DD06-002|
|Type of Funding:||Cooperative Agreement|
|CFDA Descriptions:||Centers for Disease Control and Prevention_Investigations and Technical Assistance|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Apr 24, 2006|
|Posted Date:||Feb 24, 2006|
|Creation Date:||Sep 04, 2007|
|Archive Date:||Apr 26, 2006|
|Total Program Funding:||$2,850,000|
|Maximum Federal Grant Award:||$600,000|
|Minimum Federal Grant Award:||$0|
|Expected Number of Awards:||5|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Eligible Applicants 1.A. Eligible Institutions You may submit an application for the Phase I award if your organization has any of the following characteristics: State health departments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, the Republic of Palau), and federally recognized Indian tribal governments. A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If you are applying as a bona fide agent of a state or local government, you must provide a letter from the state or local government as documentation of your status. Place this documentation behind the first page of your application form. As a requirement, applicants for the Phase I award must include and document a study population of at least 15,000 live births per year with at least 65% of the births to mothers who are Asian or Pacific Islander within a state or a contiguous area of a state (such as the catchment of a local or municipal health agency), based on U.S. Census Data. All applicants for the Phase I award that fail to submit the evidence requested above will be considered non-responsive and returned without review. Eligible applicants for Phase II are limited to those previously funded under Program Announcement Number 02172. They are: (1) University of Arizona College of Medicine, (2) Colorado Department of Public Health and Environment, (3) University of Iowa College of Medicine, and (4) the New York State Department of Health. This limited eligibility is based on sustaining support to already well-established programs, and to take advantage of the foundation, collaborations in place, and the multiple systems developed over time and now operational to conduct this research.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Centers for Disease Control and Prevention
Procurement and Grants Office
Technical Information Management Section
Phone 770-488-2700 PGOTIM@cdc.gov PGOTIM@cdc.gov
- Similar Government Grants
- • National Foundation for the Centers for Disease Control and Prevention
- • Strengthening the Nation's Public Health Communication Infrastructure to Respond to C...
- • Technical Collaboration to Strengthen and Expand Capacity to Assess, Prevent, and Mitigate...
- • Advancing the Centers of Excellence in Newcomer Health
- • Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts
- • Postdoctoral Fellowship Training Program in Infectious Diseases
- • A Cooperative Agreement to Improve the Interaction Between Public Health Academicians and ...
- • A Cooperative Agreement to Strengthen Collaboration Between the Disciplines of Academic Me...
- More Grants from the Centers for Disease Control and Prevention
- • 93.067
- • Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
- • Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...
- • Strengthening Ebola rapid detection and response capacity through community based surveill...
- • test2